| Biosimilar cost savings in the United States: initial experience and future potential AW Mulcahy, JP Hlávka, SR Case RAND Health Quarterly 7 (4), 2018 | 249 | 2018 |
| Artificial Intelligence in Healthcare A Bohr, K Memarzadeh, (editors) Academic Press, 2020 | 225 | 2020 |
| Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups National Academies of Sciences, Engineering, and Medicine https://nap.nationalacademies.org/read/26479/chapter/1, 2022 | 106 | 2022 |
| Assessing the preparedness of the US health care system infrastructure for an Alzheimer’s treatment JL Liu, JP Hlávka, R Hillestad, S Mattke The RAND Corporation, Santa Monica, CA, 2017 | 93 | 2017 |
| Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment JP Hlavka, S Mattke, JL Liu RAND Health Quarterly 8 (3), 2019 | 85 | 2019 |
| Toward a Sustainable Blood Supply in the United States AW Mulcahy, K Kapinos, B Briscombe, L Uscher-Pines, R Chaturvedi, ... Santa Monica (CA): RAND Corporation, 2016 | 61 | 2016 |
| Blood‐based biomarkers for Alzheimer's pathology and the diagnostic process for a disease‐modifying treatment: Projecting the impact on the cost and wait times MH Soeren Mattke, Sang Kyu Cho, Tobias Bittner, Jakub Hlávka Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020 | 47 | 2020 |
| Macroeconomic consequences of the COVID-19 pandemic T Walmsley, A Rose, R John, D Wei, JP Hlávka, J Machado, K Byrd Economic modelling 120, 106147, 2023 | 35 | 2023 |
| Assessing the preparedness of the Canadian health care system infrastructure for an Alzheimer's treatment J Liu, J Hlávka, D Coulter, SM Baxi, S Mattke, CA Gidengil RAND, 2019 | 26 | 2019 |
| The potential emergence of disease-modifying treatments for Alzheimer disease: the role of primary care in managing the patient journey J Lam, J Hlávka, S Mattke The Journal of the American Board of Family Medicine 32 (6), 931-940, 2019 | 23 | 2019 |
| Security Sector Reform in Ukraine O Oliker, LE Davis, K Crane, A Radin, CW Gventer, S Sondergaard, ... RAND Corporation, 2016 | 23 | 2016 |
| Security, privacy, and information-sharing aspects of healthcare artificial intelligence JP Hlávka Artificial Intelligence in Healthcare, 235-270, 2020 | 22 | 2020 |
| US Presence and the Incidence of Conflict A O’Mahony, BF Miranda Priebe, J Kavanagh, M Lane, T Johnston, ... RAND Corporation, 2018 | 21 | 2018 |
| Challenges to the Sustainability of the US Public Cord Blood System KA Kapinos, B Briscombe, T Gracner, A Strong, C Whaley, E Hoch, ... RAND Corporation, 2017 | 19 | 2017 |
| Targeted interoperability: a new imperative for multinational operations CG Pernin, J Hlávka, ME Boyer, J Gordon, J Osburg, M Lerario, M Shurkin, ... RAND, 2019 | 15 | 2019 |
| Lessons from Others for Future US Army Operations in and Through the Information Environment C Paul, CP Clarke, M Schwille, JP Hlávka, MA Brown, SS Davenport, ... RAND Corporation, 2018 | 15 | 2018 |
| 3D printing: Downstream production transforming the supply chain S Veronneau, G Torrington, JP Hlávka RAND Corporation Santa Monica United States, 2017 | 13* | 2017 |
| The economics of alternative payment models for pharmaceuticals JP Hlávka, JC Yu, DP Goldman, DN Lakdawalla The European Journal of Health Economics 22, 559-569, 2021 | 11 | 2021 |
| Assessing the preparedness of the Japanese health care system infrastructure for an Alzheimer’s treatment S Mattke, J Hlávka, J Yoong, M Wang, R Goto | 11 | 2019 |
| Biosimilar cost savings in the United States AW Mulcahy, JP Hlávka, SR Case Rand Corporation Perspective, 2017 | 9 | 2017 |
Soeren MattkeResearch Professor of Economics, University of Southern California在 usc.edu 的电子邮件经过验证
